Latest Breaking News On - Protein biomarker - Page 3 : comparemela.com

In the Relapsing-Remitting form of Multiple Sclerosis (RRMS), a single biomarker (soluble neurofilament light chain or sNfL) is identified as a biomarker for inflammatory activity in MS, but is limited in its ability to identify relapses. Through screening several hundred proteins using Olink ® technology, three additional protein biomarkers have been identified as an improved relapse-specific signature to monitor disease activity in RRMS patients.

United statesFerhan qureshiOlink cardiometabolicOklahoma medical research foundationBiomarker product development of octaveStanford universityIndustry newsMultiple sclerosisEpstein barr virusOperating characteristicsBiomarker product developmentMult scler relatIncreasing the accuracy of multiple sclerosis relapse monitoring olink proteomics msMultiple sclerosisOlink proteomicsProtein biomarker